CryoLife board approves $15 million stock buyback
Medical device maker CryoLife Inc. said Tuesday its board of directors approved a $15 million stock buyback program.
The company said the program is authorized for two years.
CryoLife has about 28.7 million shares of common stock outstanding.
Shares fell a penny to $5.17 in afternoon trading.